{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:10:36Z","timestamp":1793373036339,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s12035-015-9166-6","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:21:58Z","timestamp":1429057318000},"page":"2857-2868","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death"],"prefix":"10.1007","volume":"53","author":[{"given":"N\u00faria","family":"Mart\u00edn-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Roman\u00ed-Aumedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ru\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Canal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-4163","authenticated-orcid":false,"given":"Marco","family":"Straccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alberch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"P\u00e9rez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-436X","authenticated-orcid":false,"given":"Cristina","family":"Malagelada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"9166_CR1","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/MCB.22.7.2283-2293.2002","volume":"22","author":"T Shoshani","year":"2002","unstructured":"Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S (2002) Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 22:2283\u20132293","journal-title":"Mol Cell Biol"},{"key":"9166_CR2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1097-2765(02)00706-2","volume":"10","author":"LW Ellisen","year":"2002","unstructured":"Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F et al (2002) REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10:995\u20131005","journal-title":"Mol Cell"},{"key":"9166_CR3","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1074\/jbc.M303723200","volume":"278","author":"Z Wang","year":"2003","unstructured":"Wang Z, Malone MH, Thomenius MJ, Zhong F, Xu F, Distelhorst CW (2003) Dexamethasone-induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic signals. J Biol Chem 278:27053\u201327058","journal-title":"J Biol Chem"},{"key":"9166_CR4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm.2157","volume":"16","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Mett I, Bhunia AK, Bowman J, Perez M, Zhang L, Gandjeva A, Zhen L et al (2010) Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med 16:767\u2013773","journal-title":"Nat Med"},{"key":"9166_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/emm.2003.53","volume":"35","author":"JR Kim","year":"2003","unstructured":"Kim JR, Lee SR, Chung HJ, Kim S, Baek SH, Kim JH, Kim YS (2003) Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity. Exp Mol Med 35:403\u2013411","journal-title":"Exp Mol Med"},{"key":"9166_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nbd.2009.07.004","volume":"36","author":"M Morel","year":"2009","unstructured":"Morel M, Couturier J, Pontcharraud R, Gil R, Fauconneau B, Paccalin M, Page G (2009) Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Neurobiol Dis 36:151\u2013161","journal-title":"Neurobiol Dis"},{"key":"9166_CR7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nbd.2004.08.016","volume":"18","author":"EJ Ryu","year":"2005","unstructured":"Ryu EJ, Angelastro JM, Greene LA (2005) Analysis of gene expression changes in a cellular model of Parkinson disease. Neurobiol Dis 18:54\u201374","journal-title":"Neurobiol Dis"},{"key":"9166_CR8","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.3292-06.2006","volume":"26","author":"C Malagelada","year":"2006","unstructured":"Malagelada C, Ryu EJ, Biswas SC, Jackson-Lewis V, Greene LA (2006) RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. J Neurosci 26:9996\u201310005","journal-title":"J Neurosci"},{"key":"9166_CR9","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.333","volume":"5","author":"J Romani-Aumedes","year":"2014","unstructured":"Romani-Aumedes J, Canal M, Martin-Flores N, Sun X, Perez-Fernandez V, Wewering S, Fernandez-Santiago R, Ezquerra M et al (2014) Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease. Cell Death Dis 5, e1364","journal-title":"Cell Death Dis"},{"key":"9166_CR10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1582-4934.2009.00688.x","volume":"13","author":"M Damjanac","year":"2009","unstructured":"Damjanac M, Page G, Ragot S, Laborie G, Gil R, Hugon J, Paccalin M (2009) PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients. J Cell Mol Med 13:1823\u20131832","journal-title":"J Cell Mol Med"},{"key":"9166_CR11","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW et al (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 18:2893\u20132904","journal-title":"Genes Dev"},{"key":"9166_CR12","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","volume":"28","author":"C Malagelada","year":"2008","unstructured":"Malagelada C, Jin ZH, Greene LA (2008) RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation\/activation. J Neurosci 28:14363\u201314371","journal-title":"J Neurosci"},{"key":"9166_CR13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1042\/BST20130134","volume":"41","author":"S Sarkar","year":"2013","unstructured":"Sarkar S (2013) Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem Soc Trans 41:1103\u20131130","journal-title":"Biochem Soc Trans"},{"key":"9166_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","volume":"19","author":"K Maiese","year":"2013","unstructured":"Maiese K, Chong ZZ, Shang YC, Wang S (2013) mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med 19:51\u201360","journal-title":"Trends Mol Med"},{"key":"9166_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.mam.2006.08.008","volume":"27","author":"B Ravikumar","year":"2006","unstructured":"Ravikumar B, Rubinsztein DC (2006) Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Mol Aspects Med 27:520\u2013527","journal-title":"Mol Aspects Med"},{"key":"9166_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar S, Ravikumar B, Floto RA, Rubinsztein DC (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ 16:46\u201356","journal-title":"Cell Death Differ"},{"key":"9166_CR17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9166_CR18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"9166_CR19","first-page":"553","volume":"85","author":"DM Mann","year":"1993","unstructured":"Mann DM, Oliver R, Snowden JS (1993) The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 85:553\u2013559","journal-title":"Acta Neuropathol"},{"key":"9166_CR20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K et al (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"9166_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","volume":"23","author":"U Rub","year":"2013","unstructured":"Rub U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J et al (2013) Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23:165\u2013177","journal-title":"Brain Pathol"},{"key":"9166_CR22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","volume":"315","author":"JB Martin","year":"1986","unstructured":"Martin JB, Gusella JF (1986) Huntington's disease. Pathogenesis and management. N Engl J Med 315:1267\u20131276","journal-title":"N Engl J Med"},{"key":"9166_CR23","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1523\/JNEUROSCI.4011-10.2011","volume":"31","author":"C Malagelada","year":"2011","unstructured":"Malagelada C, Lopez-Toledano MA, Willett RT, Jin ZH, Shelanski ML, Greene LA (2011) RTP801\/REDD1 regulates the timing of cortical neurogenesis and neuron migration. J Neurosci 31:3186\u20133196","journal-title":"J Neurosci"},{"key":"9166_CR24","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","volume":"73","author":"LA Greene","year":"1976","unstructured":"Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73:2424\u20132428","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9166_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.200711167","volume":"181","author":"S Leal-Ortiz","year":"2008","unstructured":"Leal-Ortiz S, Waites CL, Terry-Lorenzo R, Zamorano P, Gundelfinger ED, Garner CC (2008) Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis. J Cell Biol 181:831\u2013846","journal-title":"J Cell Biol"},{"key":"9166_CR26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","volume":"158","author":"A Giralt","year":"2009","unstructured":"Giralt A, Rodrigo T, Martin ED, Gonzalez JR, Mila M, Cena V, Dierssen M, Canals JM et al (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience 158:1234\u20131250","journal-title":"Neuroscience"},{"key":"9166_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12017-013-8248-8","volume":"16","author":"L Rue","year":"2014","unstructured":"Rue L, Alcala-Vida R, Lopez-Soop G, Creus-Muncunill J, Alberch J, Perez-Navarro E (2014) Early down-regulation of PKCdelta as a pro-survival mechanism in Huntington's disease. Neuromol Med 16:25\u201337","journal-title":"Neuromol Med"},{"key":"9166_CR28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, Duyao MP, Vrbanac V et al (1999) Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"9166_CR29","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1093\/hmg\/ddr351","volume":"20","author":"A Giralt","year":"2011","unstructured":"Giralt A, Saavedra A, Carreton O, Xifro X, Alberch J, Perez-Navarro E (2011) Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum Mol Genet 20:4232\u20134247","journal-title":"Hum Mol Genet"},{"key":"9166_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073664","volume":"8","author":"A Saavedra","year":"2013","unstructured":"Saavedra A, Giralt A, Arumi H, Alberch J, Perez-Navarro E (2013) Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease. PLoS One 8, e73664","journal-title":"PLoS One"},{"key":"9166_CR31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cdd.2009.127","volume":"17","author":"A Saavedra","year":"2010","unstructured":"Saavedra A, Garcia-Martinez JM, Xifro X, Giralt A, Torres-Peraza JF, Canals JM, Diaz-Hernandez M, Lucas JJ et al (2010) PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K\/Akt pro-survival pathway in Huntington's disease striatum. Cell Death Differ 17:324\u2013335","journal-title":"Cell Death Differ"},{"key":"9166_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1476-5381.2011.01337.x","volume":"164","author":"XM Wu","year":"2011","unstructured":"Wu XM, Qian ZM, Zhu L, Du F, Yung WH, Gong Q, Ke Y (2011) Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. Br J Pharmacol 164:332\u2013343","journal-title":"Br J Pharmacol"},{"key":"9166_CR33","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1074\/jbc.M706643200","volume":"283","author":"SR Kimball","year":"2008","unstructured":"Kimball SR, Do AN, Kutzler L, Cavener DR, Jefferson LS (2008) Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis. J Biol Chem 283:3465\u20133475","journal-title":"J Biol Chem"},{"key":"9166_CR34","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","volume":"30","author":"C Malagelada","year":"2010","unstructured":"Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA (2010) Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci 30:1166\u20131175","journal-title":"J Neurosci"},{"key":"9166_CR35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.cellsig.2006.12.014","volume":"19","author":"HO Jin","year":"2007","unstructured":"Jin HO, An S, Lee HC, Woo SH, Seo SK, Choe TB, Yoo DH, Lee SB et al (2007) Hypoxic condition- and high cell density-induced expression of Redd1 is regulated by activation of hypoxia-inducible factor-1alpha and Sp1 through the phosphatidylinositol 3-kinase\/Akt signaling pathway. Cell Signal 19:1393\u20131403","journal-title":"Cell Signal"},{"key":"9166_CR36","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1101\/gad.1673408","volume":"22","author":"ML Duennwald","year":"2008","unstructured":"Duennwald ML, Lindquist S (2008) Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 22:3308\u20133319","journal-title":"Genes Dev"},{"key":"9166_CR37","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.yexcr.2007.12.025","volume":"314","author":"S Reijonen","year":"2008","unstructured":"Reijonen S, Putkonen N, Norremolle A, Lindholm D, Korhonen L (2008) Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins. Exp Cell Res 314:950\u2013960","journal-title":"Exp Cell Res"},{"key":"9166_CR38","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E, MacDonald ME (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9:2799\u20132809","journal-title":"Hum Mol Genet"},{"key":"9166_CR39","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","volume":"281","author":"Z Qiu","year":"2006","unstructured":"Qiu Z, Norflus F, Singh B, Swindell MK, Buzescu R, Bejarano M, Chopra R, Zucker B et al (2006) Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J Biol Chem 281:16672\u201316680","journal-title":"J Biol Chem"},{"key":"9166_CR40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jnr.21881","volume":"87","author":"J Illuzzi","year":"2009","unstructured":"Illuzzi J, Yerkes S, Parekh-Olmedo H, Kmiec EB (2009) DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates. J Neurosci Res 87:733\u2013747","journal-title":"J Neurosci Res"},{"key":"9166_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","volume":"446","author":"JI Chae","year":"2012","unstructured":"Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J 446:359\u2013371","journal-title":"Biochem J"},{"key":"9166_CR42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"HD iPSC Consortium.","year":"2012","unstructured":"HD iPSC Consortium. (2012) Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11:264\u2013278","journal-title":"Cell Stem Cell"},{"key":"9166_CR43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nbd.2010.11.018","volume":"43","author":"XJ Li","year":"2011","unstructured":"Li XJ, Li S (2011) Proteasomal dysfunction in aging and Huntington disease. Neurobiol Dis 43:4\u20138","journal-title":"Neurobiol Dis"},{"key":"9166_CR44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001756-200303240-00007","volume":"14","author":"S Igarashi","year":"2003","unstructured":"Igarashi S, Morita H, Bennett KM, Tanaka Y, Engelender S, Peters MF, Cooper JK, Wood JD et al (2003) Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport 14:565\u2013568","journal-title":"Neuroreport"},{"key":"9166_CR45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/hmg\/ddi071","volume":"14","author":"MA Poirier","year":"2005","unstructured":"Poirier MA, Jiang H, Ross CA (2005) A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure. Hum Mol Genet 14:765\u2013774","journal-title":"Hum Mol Genet"},{"key":"9166_CR46","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1523\/JNEUROSCI.4522-06.2007","volume":"27","author":"K Tagawa","year":"2007","unstructured":"Tagawa K, Marubuchi S, Qi ML, Enokido Y, Tamura T, Inagaki R, Murata M, Kanazawa I et al (2007) The induction levels of heat shock protein 70 differentiate the vulnerabilities to mutant huntingtin among neuronal subtypes. J Neurosci 27:868\u2013880","journal-title":"J Neurosci"},{"key":"9166_CR47","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1074\/jbc.M110.156521","volume":"286","author":"A Bertoni","year":"2011","unstructured":"Bertoni A, Giuliano P, Galgani M, Rotoli D, Ulianich L, Adornetto A, Santillo MR, Porcellini A et al (2011) Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins. J Biol Chem 286:4727\u20134741","journal-title":"J Biol Chem"},{"key":"9166_CR48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1476-5381.2010.00773.x","volume":"160","author":"EL Scotter","year":"2010","unstructured":"Scotter EL, Goodfellow CE, Graham ES, Dragunow M, Glass M (2010) Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease. Br J Pharmacol 160:747\u2013761","journal-title":"Br J Pharmacol"},{"key":"9166_CR49","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1523\/JNEUROSCI.0895-12.2012","volume":"32","author":"EM Sontag","year":"2012","unstructured":"Sontag EM, Lotz GP, Agrawal N, Tran A, Aron R, Yang G, Necula M, Lau A et al (2012) Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. J Neurosci 32:11109\u201311119","journal-title":"J Neurosci"},{"key":"9166_CR50","first-page":"1217","volume":"21","author":"E Perez-Navarro","year":"2006","unstructured":"Perez-Navarro E, Canals JM, Gines S, Alberch J (2006) Cellular and molecular mechanisms involved in the selective vulnerability of striatal projection neurons in Huntington's disease. Histol Histopathol 21:1217\u20131232","journal-title":"Histol Histopathol"},{"key":"9166_CR51","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.121","volume":"3","author":"G Cisbani","year":"2012","unstructured":"Cisbani G, Cicchetti F (2012) An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity. Cell Death Dis 3, e382","journal-title":"Cell Death Dis"},{"key":"9166_CR52","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1167\/iovs.04-0052","volume":"45","author":"A Brafman","year":"2004","unstructured":"Brafman A, Mett I, Shafir M, Gottlieb H, Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R et al (2004) Inhibition of oxygen-induced retinopathy in RTP801-deficient mice. Invest Ophthalmol Vis Sci 45:3796\u20133805","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9166_CR53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainresbull.2013.08.002","volume":"98","author":"S Olmo-Aguado del","year":"2013","unstructured":"del Olmo-Aguado S, Nunez-Alvarez C, Ji D, Manso AG, Osborne NN (2013) RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride. Brain Res Bull 98:132\u2013144","journal-title":"Brain Res Bull"},{"key":"9166_CR54","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1167\/iovs.13-13449","volume":"55","author":"KD Rittenhouse","year":"2014","unstructured":"Rittenhouse KD, Johnson TR, Vicini P, Hirakawa B, Kalabat D, Yang AH, Huang W, Basile AS (2014) RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801. Invest Ophthalmol Vis Sci 55:1232\u20131240","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9166_CR55","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1167\/iovs.12-9961","volume":"53","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Schachar RA, Nduaka CI, Sperling M, Basile AS, Klamerus KJ, Chi-Burris K, Yan E et al (2012) Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study). Invest Ophthalmol Vis Sci 53:7666\u20137674","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9166_CR56","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.1523\/JNEUROSCI.2408-13.2013","volume":"33","author":"R Noseda","year":"2013","unstructured":"Noseda R, Belin S, Piguet F, Vaccari I, Scarlino S, Brambilla P, Martinelli Boneschi F, Feltri ML et al (2013) DDIT4\/REDD1\/RTP801 is a novel negative regulator of Schwann cell myelination. J Neurosci 33:15295\u201315305","journal-title":"J Neurosci"},{"key":"9166_CR57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"9166_CR58","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1523\/JNEUROSCI.21-22-08772.2001","volume":"21","author":"E Martin-Aparicio","year":"2001","unstructured":"Martin-Aparicio E, Yamamoto A, Hernandez F, Hen R, Avila J, Lucas JJ (2001) Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease. J Neurosci 21:8772\u20138781","journal-title":"J Neurosci"},{"key":"9166_CR59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","volume":"11","author":"VC Wheeler","year":"2002","unstructured":"Wheeler VC, Gutekunst CA, Vrbanac V, Lebel LA, Schilling G, Hersch S, Friedlander RM, Gusella JF et al (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633\u2013640","journal-title":"Hum Mol Genet"},{"key":"9166_CR60","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P et al (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"9166_CR61","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","volume":"25","author":"M Diaz-Hernandez","year":"2005","unstructured":"Diaz-Hernandez M, Torres-Peraza J, Salvatori-Abarca A, Moran MA, Gomez-Ramos P, Alberch J, Lucas JJ (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease. J Neurosci 25:9773\u20139781","journal-title":"J Neurosci"},{"key":"9166_CR62","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/jnr.21258","volume":"85","author":"JM Garcia-Martinez","year":"2007","unstructured":"Garcia-Martinez JM, Perez-Navarro E, Xifro X, Canals JM, Diaz-Hernandez M, Trioulier Y, Brouillet E, Lucas JJ et al (2007) BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease. J Neurosci Res 85:2756\u20132769","journal-title":"J Neurosci Res"},{"key":"9166_CR63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1046\/j.0953-816x.2001.01765.x","volume":"14","author":"A Petersen","year":"2001","unstructured":"Petersen A, Hansson O, Puschban Z, Sapp E, Romero N, Castilho RF, Sulzer D, Rice M et al (2001) Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. Eur J Neurosci 14:1425\u20131435","journal-title":"Eur J Neurosci"},{"key":"9166_CR64","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, Kooperberg C, Becanovic K, Pouladi MA et al (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861","journal-title":"Hum Mol Genet"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9166-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9166-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T09:08:50Z","timestamp":1566551330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["9166"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9166-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}